Tianran Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tianran Chen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Baiyi Xie
Department of Urology Surgery, Ruikang Hospital affiliated to Guangxi University of Chinese Medicine, Nanning, China
1 shared publication Chao Han
Department of Liver Transplantation, Organ Transplantation Center Tianjin First Central Hospital Tianjin China
1 shared publication- Chao Sun
Department of Liver Transplantation, Organ Transplantation Center Tianjin First Central Hospital Tianjin China
1 shared publication Chong Dong
Department of Liver Transplantation, Organ Transplantation Center Tianjin First Central Hospital Tianjin China
1 shared publication- Chunlin Shen
Xiamen Key Laboratory of Regeneration Medicine, Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, Organ Transplantation Institute, School of Medicine, Xiamen University, Xiamen, China
1 shared publication - Dong-Feng Wan
School of Kinesiology, Shanghai University of Sport, Shanghai, China
1 shared publication
Latest Publications
- 3 March 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1610-1625
Dietary carboxymethylcellulose metabolite promotes heart allograft rejection through induction of proinflammatory macrophages via lysophosphatidic acid
- 3 March 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1610-1625
Dietary carboxymethylcellulose metabolite promotes heart allograft rejection through induction of proinflammatory macrophages via lysophosphatidic acid
- 6 February 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (2) , e70027
Post‐Liver Transplantation–Burkitt Lymphoma in Children: A Single‐Center Study of Clinical Characteristics, Treatment, and Outcomes
Background: Post‐liver transplantation–Burkitt lymphoma (PLT‐BL) is an aggressive and life‐threatening complication after pediatric liver transplantation. The research on the disease characteristics, treatment, and prognosis of pediatric PLT‐BL is limited.Methods: A retrospective, observational study was performed to analyze the disease characteristics, treatment, and outcomes in 12 pediatric liver transplant (LT) recipients diagnosed with PLT‐BL.Results: The medium time from liver transplantation to diagnosis was 32.71 months (range, 25.78–37.85 months). All patients (100%) tested positive for EBV viremia at diagnosis. Abdomen and peripheral lymph nodes were the most frequently involved sites (11 [91.66%] and 10 [83.33%], respectively). Three pediatric patients were diagnosed as relapsed or refractory PLT‐BL and treated with chimeric antigen receptor (CAR) T‐cell therapy, and two of them achieved complete remission (CR). Nine patients were alive with CR at the last follow‐up. Three deaths were attributed to progression and tumor lysis syndrome, characterized by significantly elevated lactate dehydrogenase (LDH) levels (p = 0.027), more advanced tumor stages (p = 0.045), and an increased number of involved sites (p = 0.009). With a median follow‐up of 2.7 years after diagnosis, the event‐free survival (EFS) and overall survival (OS) rates for PLT‐BL patients were 66.7% and 74.1%, respectively. In four patients, immunosuppression was successfully withdrawn and they maintained tolerance status.Conclusion: Elevated LDH levels, more advanced tumor stages, and increased number of involved sites are potentially associated with poor outcome. Immunosuppression withdrawal is a safe and feasible approach for PLT‐BL.
- 6 February 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (2) , e70027
Post‐Liver Transplantation–Burkitt Lymphoma in Children: A Single‐Center Study of Clinical Characteristics, Treatment, and Outcomes
Background: Post‐liver transplantation–Burkitt lymphoma (PLT‐BL) is an aggressive and life‐threatening complication after pediatric liver transplantation. The research on the disease characteristics, treatment, and prognosis of pediatric PLT‐BL is limited.Methods: A retrospective, observational study was performed to analyze the disease characteristics, treatment, and outcomes in 12 pediatric liver transplant (LT) recipients diagnosed with PLT‐BL.Results: The medium time from liver transplantation to diagnosis was 32.71 months (range, 25.78–37.85 months). All patients (100%) tested positive for EBV viremia at diagnosis. Abdomen and peripheral lymph nodes were the most frequently involved sites (11 [91.66%] and 10 [83.33%], respectively). Three pediatric patients were diagnosed as relapsed or refractory PLT‐BL and treated with chimeric antigen receptor (CAR) T‐cell therapy, and two of them achieved complete remission (CR). Nine patients were alive with CR at the last follow‐up. Three deaths were attributed to progression and tumor lysis syndrome, characterized by significantly elevated lactate dehydrogenase (LDH) levels (p = 0.027), more advanced tumor stages (p = 0.045), and an increased number of involved sites (p = 0.009). With a median follow‐up of 2.7 years after diagnosis, the event‐free survival (EFS) and overall survival (OS) rates for PLT‐BL patients were 66.7% and 74.1%, respectively. In four patients, immunosuppression was successfully withdrawn and they maintained tolerance status.Conclusion: Elevated LDH levels, more advanced tumor stages, and increased number of involved sites are potentially associated with poor outcome. Immunosuppression withdrawal is a safe and feasible approach for PLT‐BL.
- 4 February 2021
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 52 (2) , 373-383
Comparison of myocardial ischemic/hypoxic staining techniques for evaluating the alleviation of exhaustive exercise-induced myocardial injury by exercise preconditioning
Exercise preconditioning (EP) can alleviate myocardial ischemic/hypoxic injury by inducing endogenous cardioprotection. Hematoxylin–eosin (HE), hematoxylin-basic fuchsin-picric acid (HBFP), and chromotrope-2R brilliant green (C-2R BG) staining have been used to visualize myocardial ischemic/hypoxic changes in previous EP studies, but comprehensive evaluation and comparisons of these methods are lacking. This study evaluated ischemic/hypoxic changes in adjacent myocardial sections by HE, HBFP, and C-2R BG and compared the characteristics of sections stained by these three methods to show changes associated with exercise-induced myocardial ischemic/hypoxic injury. Rats were randomly divided into four groups: control (C), exercise preconditioning (EP), exhaustive exercise (EE), and exercise preconditioning + exhaustive exercise (EP + EE). Adjacent myocardial sections were stained as described above and compared to evaluate the effects of exercise-induced myocardial ischemic/hypoxic injury. The three staining methods revealed consistent localization patterns of myocardial ischemic/hypoxic injury in all groups. Results suggest that EP can alleviate exhaustive exercise-induced myocardial ischemic/hypoxic injury, and the three staining methods are suitable for the histological study of exercise-induced myocardial ischemic/hypoxic injury and protection. HE staining is a simple procedure but is not specific for myocardial ischemic/hypoxic injury. HBFP and C-2R BG staining can be used to specifically visualize myocardial ischemic/hypoxic injury.
- 4 February 2021
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 52 (2) , 373-383
Comparison of myocardial ischemic/hypoxic staining techniques for evaluating the alleviation of exhaustive exercise-induced myocardial injury by exercise preconditioning
Exercise preconditioning (EP) can alleviate myocardial ischemic/hypoxic injury by inducing endogenous cardioprotection. Hematoxylin–eosin (HE), hematoxylin-basic fuchsin-picric acid (HBFP), and chromotrope-2R brilliant green (C-2R BG) staining have been used to visualize myocardial ischemic/hypoxic changes in previous EP studies, but comprehensive evaluation and comparisons of these methods are lacking. This study evaluated ischemic/hypoxic changes in adjacent myocardial sections by HE, HBFP, and C-2R BG and compared the characteristics of sections stained by these three methods to show changes associated with exercise-induced myocardial ischemic/hypoxic injury. Rats were randomly divided into four groups: control (C), exercise preconditioning (EP), exhaustive exercise (EE), and exercise preconditioning + exhaustive exercise (EP + EE). Adjacent myocardial sections were stained as described above and compared to evaluate the effects of exercise-induced myocardial ischemic/hypoxic injury. The three staining methods revealed consistent localization patterns of myocardial ischemic/hypoxic injury in all groups. Results suggest that EP can alleviate exhaustive exercise-induced myocardial ischemic/hypoxic injury, and the three staining methods are suitable for the histological study of exercise-induced myocardial ischemic/hypoxic injury and protection. HE staining is a simple procedure but is not specific for myocardial ischemic/hypoxic injury. HBFP and C-2R BG staining can be used to specifically visualize myocardial ischemic/hypoxic injury.